Jan 18, 2017
On December 8th in Tokyo, Locust Walk hosted the 2nd annual “Locust Walk Japan Deal of the Year Award” event. We founded this event, which is co-sponsored by Clarivate Analytics (formerly Thomson Reuters), to celebrate the deals consummated throughout the year by...
Dec 21, 2016
Downward pricing pressures, restrictions on sales representation within hospitals and a push towards value based healthcare fostered ongoing uncertainty in the Medical Device Industry in 2016. Companies responded by consolidating, leveraging commercial infrastructures...
Dec 14, 2016
Last week, both chambers of Congress voted nearly unanimously to pass the 21st Century Cures Act (the Cures Act), sweeping legislation that directly impacts the government funding and FDA review process of medical innovations, both pharmaceutical and device. ...
Dec 7, 2016
This week Locust Walk announced the opening of our first office in Europe, which will initially be in Germany. Since this is a big step for our firm and builds on our success in Japan, we wanted to share the rationale for why we thought going into Europe made sense....
Dec 1, 2016
The recent flurry of partnering deals for Immuno-Oncology (IO) technologies surpasses the deal activity for any other technology at any other time in biotech history. In the past two years, there have been 31 development stage IO deals with up-front values greater...
